Daclizumab discontinue letter for the US market Food and Drug Administration/Roche, Sep 2009 Accessed on 3 Dec 2011 from http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM194907.pdf. CommentRecommendBookmarkWatch